GlyProVac competitorsClear all

GlyProVac's top competitors include Prosetta and Aprogen.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
GlyProVac
GlyProVac
GlyProVac is a company pursuing the development of glycoprotein based vaccines.
Prosetta
Prosetta
Prosetta Corporation operates as a biopharmaceutical company in the United States.
Aprogen
Aprogen
Aprogen is a biologics platform company focused on developing and manufacturing biosimilar products, protein drugs, and bispecific antibodies.
Founding Date
Founding Date
2018
Founding Date
N/A
Founding Date
2000
Type
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Odense, DK HQ
Locations
San Francisco, US HQ
Locations
HQ
Employees
Employees
7
Employees
284% increase
Employees
693% increase
Employee Rating
Employee Rating
N/A
Employee Rating
3
Employee Rating
3

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 2m (about 15 years ago)
Latest funding round
$ 16.7m (over 2 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 2m
Total funding raised
$ 16.7m
For sources of this data, please see the company profile

View company profiles

Prosetta
HQ
San Francisco, US
Employees
28↑ 4% increase

Prosetta Corporation operates as a biopharmaceutical company in the United States.

View company
Aprogen
HQ
Employees
69↑ 3% increase

Aprogen is a biologics platform company focused on developing and manufacturing biosimilar products, protein drugs, and bispecific antibodies.

View company